Portnoy Law Firm Announces Class Action on Behalf of Picard Medical, Inc. Investors

Core Viewpoint - Picard Medical, Inc. is facing a class action lawsuit due to allegations of fraudulent activities that misled investors during a specific period, leading to significant stock price declines [1][3]. Group 1: Class Action Details - The class action is on behalf of investors who purchased securities between September 5, 2025, and October 31, 2025, with a deadline for filing a lead plaintiff motion set for April 3, 2026 [1]. - Investors are encouraged to contact the Portnoy Law Firm for legal rights discussions and case evaluations [2]. Group 2: Allegations Against Picard Medical - The complaint alleges that Picard failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [3]. - It is claimed that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [3]. - The company's public statements and risk disclosures reportedly omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [3]. Group 3: Stock Price Impact - On October 24, 2025, Picard's stock price experienced a drastic decline of 70%, dropping to $3.99 per share, and has since further decreased to approximately $2.00 per share [3].